StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / immunoact.com

ImmunoACT (Immunoadoptive Cell Therapy Pvt. Ltd.)

ImmunoACT (Immunoadoptive Cell Therapy Pvt. Ltd.) (immunoact.com): 4 changes recorded in its website history since August 2021. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeCelebrating 2 Years of Transforming Lives
    AfterImmunoACT partners with Cipla to launch Talicabtagene autoleucel in Africa

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    BeforeIndia’s 1st Indigenous CAR-T Cell Therapy
    AfterCelebrating 2 Years of Transforming Lives

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  4. HeadlineBetween and
    BeforeImmunoACT, an IIT-Bombay spin-off incubated at SINE, is India's first gene-modified cell therapy company, fully integrated from R&D to Ma…
    AfterIndia’s 1st Indigenous CAR-T Cell Therapy

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 14 August 2021

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

IIT Bombay spin-off company, incubated at SINE, driving India's first CAR-T cell therapy

Pioneer in India's first indigenous CAR-T cell therapy

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2026 – November 2026 · 2 captures · latest observed messagingImmunoACT partners with Cipla to launch Talicabtagene autoleucel in Africa

    ImmunoACT delivers India’s leading CAR-T cell therapy for blood cancer treatment, lymphoma treatment, and leukemia care. Learn how indigenous CAR-T advances affordable cancer treatment nationwide.

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 2 captures in this group
    • 16 July 2026 · ImmunoACT partners with Cipla to launch Talicabtagene autoleucel in Africa archived page
    • 6 November 2026 · ImmunoACT partners with Cipla to launch Talicabtagene autoleucel in Africa current websiteHistorical capture not publicly available
  2. Seen January 2026 · 1 captureCelebrating 2 Years of Transforming Lives

    ImmunoACT delivers India’s leading CAR-T cell therapy for blood cancer treatment, lymphoma treatment, and leukemia care. Learn how indigenous CAR-T advances affordable cancer treatment nationwide.

    This wording observed 17 January 2026.

    archived page
  3. August 2021 – July 2025 · 8 capturesIndia’s 1st Indigenous CAR-T Cell Therapy

    India’s 1st Indigenous CAR-T Cell Therapy Impact of NexCAR 19 90% Remission Rate 200+ Patients Treated 2x Likely To Stay Cancer-free 2yrs Longest Remission Rate Our Manufacturing Facility Harnessing Y

    This wording observed 9 July 2025.

    archived page
    Inspect 8 captures in this group
    • 14 August 2021 · IIT Bombay spin-off company, incubated at SINE, driving India's first CAR-T cell therapy archived page
    • 27 January 2022 · ImmunoACT: an IIT Bombay spin-off company, incubated at SINE Driving India's first CAR-T cell therapy archived page
    • 13 August 2022 · ImmunoACT: an IIT Bombay spin-off company, incubated at SINE Driving India's first CAR-T cell therapy archived page
    • 6 February 2023 · ImmunoACT: an IIT Bombay spin-off company, incubated at SINE Driving India's first CAR-T cell therapy archived page
    • 28 September 2023 · ImmunoACT: an IIT Bombay spin-off company, incubated at SINE Driving India's first CAR-T cell therapy archived page
    • 12 July 2024 · ImmunoACT, an IIT-Bombay spin-off incubated at SINE, is India's first gene-modified cell therapy company, fully integrated from R&D to Manufacturing and Commercialization. Our goal is bringing innovat archived page
    • 7 January 2025 · ImmunoACT, an IIT-Bombay spin-off incubated at SINE, is India's first gene-modified cell therapy company, fully integrated from R&D to Manufacturing and Commercialization. Our goal is bringing innovat archived page
    • 9 July 2025 · India’s 1st Indigenous CAR-T Cell Therapy archived page

Cite this record

StartupHistory, “ImmunoACT (Immunoadoptive Cell Therapy Pvt. Ltd.)” company record, https://startuphistory.org/c/immunoact.com

Machine-readable: /c/immunoact.com.json. How changes are found: method.